These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 35672148)

  • 21. Established Beta Amyloid Pathology Is Unaffected by TREM2 Elevation in Reactive Microglia in an Alzheimer's Disease Mouse Model.
    Yuan Q; Liu X; Zhang Y; Xian YF; Zou J; Zhang X; Huang P; Song YQ; Lin ZX
    Molecules; 2021 May; 26(9):. PubMed ID: 34064330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble TREM2 inhibits secondary nucleation of Aβ fibrillization and enhances cellular uptake of fibrillar Aβ.
    Belsare KD; Wu H; Mondal D; Bond A; Castillo E; Jin J; Jo H; Roush AE; Pilla KB; Sali A; Condello C; DeGrado WF
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35082148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
    Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
    Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.
    Lee J; Kim DE; Griffin P; Sheehan PW; Kim DH; Musiek ES; Yoon SY
    Aging Cell; 2020 Feb; 19(2):e13078. PubMed ID: 31800167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.
    Parhizkar S; Arzberger T; Brendel M; Kleinberger G; Deussing M; Focke C; Nuscher B; Xiong M; Ghasemigharagoz A; Katzmarski N; Krasemann S; Lichtenthaler SF; Müller SA; Colombo A; Monasor LS; Tahirovic S; Herms J; Willem M; Pettkus N; Butovsky O; Bartenstein P; Edbauer D; Rominger A; Ertürk A; Grathwohl SA; Neher JJ; Holtzman DM; Meyer-Luehmann M; Haass C
    Nat Neurosci; 2019 Feb; 22(2):191-204. PubMed ID: 30617257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TREM2 alters the phagocytic, apoptotic and inflammatory response to Aβ
    Akhter R; Shao Y; Formica S; Khrestian M; Bekris LM
    Mol Immunol; 2021 Mar; 131():171-179. PubMed ID: 33461764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of TREM2/DAP12 complex affecting β-amyloid plaque deposition in Alzheimer's disease modeled mice through mediating inflammatory response.
    Cui X; Qiao J; Liu S; Wu M; Gu W
    Brain Res Bull; 2021 Jan; 166():21-28. PubMed ID: 33053435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease.
    Zhao P; Xu Y; Jiang L; Fan X; Li L; Li X; Arase H; Zhao Y; Cao W; Zheng H; Xu H; Tong Q; Zhang N; An Z
    Sci Transl Med; 2022 Sep; 14(661):eabq0095. PubMed ID: 36070367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into the role of TREM2 in Alzheimer's disease.
    Gratuze M; Leyns CEG; Holtzman DM
    Mol Neurodegener; 2018 Dec; 13(1):66. PubMed ID: 30572908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model.
    Zhong L; Xu Y; Zhuo R; Wang T; Wang K; Huang R; Wang D; Gao Y; Zhu Y; Sheng X; Chen K; Wang N; Zhu L; Can D; Marten Y; Shinohara M; Liu CC; Du D; Sun H; Wen L; Xu H; Bu G; Chen XF
    Nat Commun; 2019 Mar; 10(1):1365. PubMed ID: 30911003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.
    Zhou J; Yu W; Zhang M; Tian X; Li Y; Lü Y
    Neurochem Res; 2019 May; 44(5):1138-1151. PubMed ID: 30756214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential interaction with TREM2 modulates microglial uptake of modified Aβ species.
    Joshi P; Riffel F; Satoh K; Enomoto M; Qamar S; Scheiblich H; Villacampa N; Kumar S; Theil S; Parhizkar S; Haass C; Heneka MT; Fraser PE; St George-Hyslop P; Walter J
    Glia; 2021 Dec; 69(12):2917-2932. PubMed ID: 34427354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TREM2 Function in Alzheimer's Disease and Neurodegeneration.
    Ulrich JD; Holtzman DM
    ACS Chem Neurosci; 2016 Apr; 7(4):420-7. PubMed ID: 26854967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid-β by microglia.
    Huang S; Liao X; Wu J; Zhang X; Li Y; Xiang D; Luo S
    FEBS Lett; 2022 Apr; 596(8):1059-1071. PubMed ID: 35292963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models.
    Lee CYD; Daggett A; Gu X; Jiang LL; Langfelder P; Li X; Wang N; Zhao Y; Park CS; Cooper Y; Ferando I; Mody I; Coppola G; Xu H; Yang XW
    Neuron; 2018 Mar; 97(5):1032-1048.e5. PubMed ID: 29518357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease.
    Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T
    Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model.
    Wang Y; Cella M; Mallinson K; Ulrich JD; Young KL; Robinette ML; Gilfillan S; Krishnan GM; Sudhakar S; Zinselmeyer BH; Holtzman DM; Cirrito JR; Colonna M
    Cell; 2015 Mar; 160(6):1061-71. PubMed ID: 25728668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CARD9 attenuates Aβ pathology and modifies microglial responses in an Alzheimer's disease mouse model.
    Ennerfelt H; Holliday C; Shapiro DA; Zengeler KE; Bolte AC; Ulland TK; Lukens JR
    Proc Natl Acad Sci U S A; 2023 Jun; 120(24):e2303760120. PubMed ID: 37276426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways.
    Wang S; Sudan R; Peng V; Zhou Y; Du S; Yuede CM; Lei T; Hou J; Cai Z; Cella M; Nguyen K; Poliani PL; Beatty WL; Chen Y; Cao S; Lin K; Rodrigues C; Ellebedy AH; Gilfillan S; Brown GD; Holtzman DM; Brioschi S; Colonna M
    Cell; 2022 Oct; 185(22):4153-4169.e19. PubMed ID: 36306735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.